ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,259Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 1383

$1.36M Total Retail Price of All Prescriptions

Rank: 19 out of 1383

664 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 664 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

25% of this provider’s 664 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 17,876 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 1,037 831 S3 1 1
LISINOPRIL 904 679 2 3
LEVOTHYROXINE SODIUM 759 609 3 4
SIMVASTATIN 633 404 4 2
FUROSEMIDE 632 546 5 7
OMEPRAZOLE 595 389 6 5
SERTRALINE HCL 504 407 7 21
AMLODIPINE BESYLATE 471 407 8 6
METFORMIN HCL ER 414 284 9 47
GABAPENTIN 408 317 10 11
RANITIDINE HCL 392 238 11 19
GLIMEPIRIDE 368 278 12 31
TRAMADOL HCL 333 250 13 25
CITALOPRAM HBR 332 300 14 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 327 202 15 27
WARFARIN SODIUM 286 262 16 13
HYDROCHLOROTHIAZIDE 284 199 17 10
CARVEDILOL 282 233 18 24
METOPROLOL TARTRATE 279 248 19 9
ZOLPIDEM TARTRATE 267 178 20 17
METFORMIN HCL 266 168 21 8
RISPERIDONE 253 196 22 71
FAMOTIDINE 252 208 23 61
TAMSULOSIN HCL 228 146 24 30
CLOPIDOGREL 203 185 25 28
POTASSIUM CHLORIDE 203 183 25 12
LOVASTATIN 199 184 27 22
QUETIAPINE FUMARATE 194 188 28 70
MELOXICAM 186 145 29 20
MIRTAZAPINE 186 179 29 51
SPIRIVA 183 103 31 45
BACLOFEN 180 78 32 118
ATENOLOL 180 121 32 16
PANTOPRAZOLE SODIUM 179 126 34 32
FLUTICASONE PROPIONATE 178 103 35 39
KLOR-CON M20 159 159 36 100
NEXIUM 159 86 36 26
PROMETHAZINE HCL 153 93 R 38 56
METOPROLOL SUCCINATE 152 131 39 29
POLYETHYLENE GLYCOL 3350 146 128 40 64
NITROFURANTOIN MONO-MACRO 141 107 41 193
FLUOXETINE HCL 136 86 42 52
PLAVIX 132 108 43 43
FENTANYL 128 98 S2 44 92
CYMBALTA 128 52 44 53
LOSARTAN POTASSIUM 126 102 46 23
DIVALPROEX SODIUM 121 97 47 78
ADVAIR DISKUS 121 94 47 63
PROAIR HFA 121 45 47 42
DONEPEZIL HCL 120 118 50 35
OXYCODONE-ACETAMINOPHEN 120 109 S2 50 107
PREDNISONE 119 103 52 40
NAMENDA 118 108 53 49
VENTOLIN HFA 115 51 54 93
CYCLOBENZAPRINE HCL 113 67 R 55 69
TRIAMTERENE-HCTZ 113 87 55 48
AMLODIPINE BESYLATE-BENAZEPRIL 112 74 57 68
LANTUS 111 69 58 50
TRAZODONE HCL 110 60 59 36
SPIRONOLACTONE 107 80 60 67
PROPRANOLOL HCL 103 99 61 129
LOSARTAN-HYDROCHLOROTHIAZIDE 102 89 62 60
CLONIDINE HCL 102 78 62 44
AMITRIPTYLINE HCL 100 70 R 64 57
GLYBURIDE 100 87 R 64 46
INSULIN SYRINGE 99 50 66 83
VENLAFAXINE HCL ER 96 55 67 102
LEVEMIR 94 80 68 145
ESCITALOPRAM OXALATE 93 82 69 99
BUMETANIDE 92 88 70 122
TRICOR 90 40 71 125
EXELON 89 89 72 117
DIOVAN 88 68 73 58
IBUPROFEN 87 63 74 91
DIOVAN HCT 86 65 75 103
BENAZEPRIL HCL 86 85 75 38
ATORVASTATIN CALCIUM 83 67 77 18
DOXYCYCLINE HYCLATE 80 57 78 94
DIGOXIN 78 72 79 59
ALLOPURINOL 77 64 80 33
OXYBUTYNIN CHLORIDE ER 76 64 81 173
AZITHROMYCIN 75 60 82 41
SULFAMETHOXAZOLE-TRIMETHOPRIM 74 55 83 89
CRESTOR 73 39 84 34
SINGULAIR 73 39 84 82
CIPROFLOXACIN HCL 72 51 86 54
NOVOLOG 71 61 87 139
HYDRALAZINE HCL 69 65 88 86
FLUCONAZOLE 69 42 88 136
PRAVASTATIN SODIUM 69 58 88 14
ACETAMINOPHEN-CODEINE 67 53 S3 91 163
BYSTOLIC 67 57 91 181
ALENDRONATE SODIUM 66 57 93 37
JANUMET 65 34 94 226
ESTRADIOL 64 32 R 95 96
SEROQUEL 64 60 95 130
NOVOLIN 70-30 63 59 97 211
LANTUS SOLOSTAR 63 0 97 112
DIVALPROEX SODIUM ER 62 22 99 200
HYDROXYZINE HCL 61 47 R 100 151
FENOFIBRATE 60 53 101 65
TRIAMCINOLONE ACETONIDE 60 40 101 159
HALOPERIDOL 58 49 103 195
PRADAXA 58 55 103 233
METOCLOPRAMIDE HCL 58 32 103 127
NYSTATIN-TRIAMCINOLONE 58 22 103 275
NITROGLYCERIN PATCH 57 56 107 177
ENABLEX 57 37 107 253
EVISTA 57 44 107 152
PHENYTOIN SODIUM EXTENDED 56 35 110 137
TERAZOSIN HCL 56 47 110 111
PEN NEEDLE 54 18 112 147
VERAPAMIL ER 54 35 112 84
NAPROXEN 52 44 114 105
ISOSORBIDE DINITRATE 51 47 115 216
PREMARIN 51 21 R 115 123
DEXILANT 50 0 117 140
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.